DermaLumics‘ success has only been possible due the credibility and the sustainability that was given to his project by their investors
Caixa Capital Risc, the venture capital arm of “La Caixa”, is an investor that provides equity and convertible loans to innovative companies in their early stages.
It uses a variety of specialized financial instruments to invest in the seed phase and provides support during the Series A and B rounds, if necessary.
Caixa Capital Risc manages a capital of 144 million euros and invests mainly in Spanish companies in the following fields:
In addition to investment, it provides intense backup to support entrepreneurs throughout Spain. Through the Emprendedor XXI award, the La Caixa Group promotes training initiatives that provide visibility to new companies with high potential, while facilitating the generation of added value contacts.
Caixa Capital Risc invests in the early stages of innovative companies through convertible loans or equity. The company currently has investments in 115 companies: 37 companies through equity, 78 through convertible loans.
The companies in their portfolio are led by highly committed entrepreneurs who have the technical and managerial skills to develop the project, operate in large or growing markets across the world and work with market-proven technology with an innovative and profitable value proposition.
The life sciences portfolio includes: